LINQ II Insertable Cardiac Monitor vs Myocardial Strain

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Circle Cardiovascular Imaging Inc.

AI Verdict

Tool A, the Medtronic LINQ II, is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and arrhythmia diagnosis. In contrast, Tool B, Circle Cardiovascular Imaging's Myocardial Strain, is software that analyzes cardiac imaging (CMR, CCT) to assess myocardial function and detect dysfunction. While both leverage AI in cardiology, they serve distinct diagnostic purposes and are not direct competitors.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II Insertable Cardiac Monitor if you require long-term, continuous monitoring of heart rhythms for patients with suspected infrequent arrhythmias, unexplained syncope, or cryptogenic stroke. Its AI-powered accuracy and remote programming capabilities enable efficient diagnosis and management over several years, even for pediatric patients, without requiring frequent in-person visits.

View LINQ II Insertable Cardiac Monitor →

Choose Myocardial Strain if…

Choose Circle Cardiovascular Imaging's Myocardial Strain if your clinical practice requires advanced, AI-powered quantification of cardiac muscle function from Cardiovascular Magnetic Resonance (CMR) and Cardiac Computed Tomography (CCT) images. This tool is ideal for the early detection and detailed assessment of myocardial dysfunction, providing comprehensive global and regional strain analysis to inform treatment decisions in conditions like cardiomyopathy or post-myocardial infarction.

View Myocardial Strain →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor Myocardial Strain
Pricing Unknown Contact for pricing
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. On-premise
FDA Status Cleared AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool A offers a patient-facing mobile app (MyCareLink Heartu2122) and remote programming, enabling continuous monitoring and data transmission by patients, alongside clinician management. This broadens its usability to include patients directly in their care, offering convenience and accessibility beyond a clinical workstation.

Clinical Value

LINQ II Insertable Cardiac Monitor

Tool A provides long-term, continuous heart rhythm monitoring with AI-powered AccuRhythmu2122 algorithms for enhanced accuracy in diagnosing arrhythmias, including an innovative PVC detection algorithm. This addresses a critical need for detecting intermittent cardiac events over an extended period (up to 4.5 years), directly impacting diagnosis and treatment for a wide patient population.

Pricing & Value

Tie

Both tools utilize an enterprise pricing model that is not publicly disclosed and requires direct contact with the vendor for details. Neither offers a free trial. Without transparent pricing or publicly available return on investment (ROI) studies, it is impossible to determine which tool offers superior value.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool A, from Medtronic, is FDA cleared, HIPAA compliant, and offers a hybrid deployment model, making it highly adaptable for various healthcare system infrastructures. With over 1 million patients having received a Medtronic ICM worldwide, it demonstrates extensive proven scalability and integration capabilities within large health systems.

Innovation

LINQ II Insertable Cardiac Monitor

Tool A showcases innovation through its miniaturized insertable design, extended battery life (up to 4.5 years), remote programming capabilities, and advanced AccuRhythmu2122 AI algorithms for precise arrhythmia detection. This combination of patient-centric, long-term, and remotely managed AI diagnostics represents a significant advancement in cardiac monitoring technology.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic provides extensive support resources, including patient service specialists available by phone, comprehensive patient and clinician manuals, and dedicated app support with FAQs and troubleshooting guides for the MyCareLink Heartu2122 app. This broad and accessible support infrastructure caters to both patients and healthcare professionals, ensuring comprehensive assistance.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor Myocardial Strain
Product Name LINQ II Insertable Cardiac Monitor Myocardial Strain
Company Medtronic Circle Cardiovascular Imaging
Core Function Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. AI-powered myocardial strain analysis for comprehensive assessment of cardiac function from CMR and CCT images, aiding in early detection of myocardial dysfunction.
Mobile App Availability both (MyCareLink Heartu2122 mobile app) Not specified
Key AI Feature AccuRhythmu2122 AI algorithms for enhanced accuracy AI-based myocardial deformation analysis
Specialties Cardiology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Myocardial Strain.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias, utilizing data from an insertable cardiac monitor. Circle Cardiovascular Imaging's Myocardial Strain tool focuses on assessing cardiac function through AI-powered analysis of Cardiovascular Magnetic Resonance (CMR) and Cardiac Computed Tomography (CCT) images.
The LINQ II utilizes AccuRhythm AI algorithms and an innovative PVC detection algorithm to enhance the accuracy of arrhythmia diagnosis from continuous ECG data. In contrast, the Myocardial Strain tool employs AI for myocardial deformation analysis, including semi-automated contour delineation and automated tracking of myocardial features from cardiac imaging.
Yes, the Medtronic LINQ II provides long-term, continuous heart rhythm monitoring for up to 4.5 years. The Myocardial Strain tool, however, performs an analysis of cardiac function from specific imaging studies rather than continuous, long-term monitoring.
The Medtronic LINQ II has a pediatric indication, suitable for patients aged 2 and older. The Myocardial Strain tool does not explicitly mention a pediatric indication, and its CT Strain feature is noted for research use only.
The Myocardial Strain tool supports analysis of both Cardiovascular Magnetic Resonance (CMR) imaging and Cardiac Computed Tomography (CCT) imaging. It's important to note that the CT Strain feature for CCT images is currently for research use only.
The LINQ II facilitates data transmission through the MyCareLink Heart mobile app or the MyCareLink Relay home communicator, allowing for remote management. The Myocardial Strain tool ensures seamless workflow integration and data access through its DICOM and PACS connectivity.
AI Tool Finder
AI-powered search. Results may not be comprehensive.